Last reviewed · How we verify
OT202 conc 0.5%
At a glance
| Generic name | OT202 conc 0.5% |
|---|---|
| Also known as | Investigational product |
| Sponsor | Ocumension Therapeutics (Shanghai) Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |